MedTrace Logo

Analisis of Facors Involved in Antidepressant Treatment Response of Major Depressive Disorder

NCT01454635 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2011-10-31

No results posted yet for this study

Summary

The purpose of this study is to predict and visualize sertraline treatment response in major depressive disorder with clinical symptoms, demographic and stress state, personality, eight genetic polymorphisms at baseline.

Conditions

Interventions

DRUG

Sertraline

dosage,frequency and duration

Sponsors & Collaborators

  • Showa University

    lead OTHER

Principal Investigators

  • Yuji Kiuchi, Professor · Showa University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01454635 on ClinicalTrials.gov